Dr. Keshav Singh, Dr. Praveen Tagore, Dr. Jal Singh Narwaria, Dr. Rakesh Patel


BACKGROUND: The Morbidity and mortality due to non-communicable diseases specially attributed to diabetes
mellitus (DM) and coronary Artery disease (CAD) is rising rapidly in India, causing nearly 5.8 million deaths per year
annually. Considering the strong association between the levels of serum uric acid (SUA) and the occurrence of coronary
atherosclerosis in subjects with type 2 diabetes mellitus, the current study has been undertaken to assess the factors
influencing the serum uric acid levels in patients with type 2diabetes mellitus.
AIMS AND OBJECTIVES: 1.To study the level of SUA in patients with type 2 DM, 2.To establish the association of
elevated serum uric acid concentration as a risk factor for CAD in type–2 diabetes patients.
RESULTS: Mean serum uric acid value is significantly higher in type II diabetes patients (5.76±1.15) than controls
(3.39±0.56). Mean serum uric acid value is significantly higher in Diabetic patients with CAD (6.115±0.87) than non CAD
patients (5.43±0.59).
CONCLUSION: Level of serum uric acid is related to duration of diabetes mellitus. It is an independent predictor of CAD
in DM patients thus can be used as a marker of CAD in type II DM patients.


Serum Uric Acid, Diabetes Mellitus, Coronary Artery Disease

Full Text:



Shrivastava U, Misra A, Mohan V, Unnikrishnan R, Bachani D. Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges. Current diabetes reviews. 2016.

Kakkar R. Rising burden of Diabetes-Public Health Challenges and way out. Nepal journal of epidemiology. 2016;6(2):557-9.

Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Annuals of global health. 2016;82(2):307-15.

Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Pal A, et al. Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India. Diabetes & metabolic syndrome. 2016.

American diabetes association. Diagnosis and classification of diabetes mellitus. Diabetic care. 2012;35(1):64-71.

National clinical guideline for management in primary and secondary care. Type 2 diabetes. Royal college of physicians. 2002;1:259.

W.H.O Consultation. Definition, Diagnosis and Classification of diabetes mellitus and its complications. World health organization. Dept. of Noncommuniable disease surveillance.WHO/NCD/NCS/99.(2).1999;(1)-49.

Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008;125:232.

Thanassoulis G, Brophy JM, Richard H, Pilote L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med. 2010;170:1358-64.

Dehghan A, Van hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31(2):361-2.

Garliardi AC, Miname MH, Santos RD. Uric Acid: A marker of increased cardiovascular risk. Atherosclerosis. 2009;202(1):11-7.

SudhindraRao M , Bino John Sahayo; A study of serum uric acid in diabetes mellitus and prediabetes in a south Indian tertiary care hospital; NUJHS Vol. 2, No.2, June 2012, ISSN 2249-7110.

M. Modan,H, Halkin A, Karasik A. Lusky- Elevated serum uric acid — a facet of hyperinsulinaemia; Diabetologia. September1987;30(9):713-718 .

Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers; Eur J Epidemiol. 2003; 18(6):523-30.

SinanDeveci O. The association between serum uric acid level and coronary artery disease. Int J ClinPract. 2010 Jun;64(7):900-7.

Cerezo C, Ruilope LM. Uric Acid and Cardiovascular Risk Considered. Am J Med. 2012;23:234-45.


  • There are currently no refbacks.